Pharmafile Logo

Webcast: Rich in potential – Exploring the opportunity for nutritionals in emerging markets

Watch the webcast: http://bit.ly/2oTpzFj

A shift to preventative health has seen nutritionals emerge as a rapidly developing area in recent years. But while growth begins to level off in more established territories, attention is turning to emerging markets. In this webcast emerging market experts Paul Reed and Kira Pillai, explore the challenges and opportunities for the nutritionals sector in some of the world’s fastest growing markets.

Key areas that will be discussed:

Drivers and cross-industry appeal
We will identify the core drivers of the nutritional phenomenon and outline why it is an attractive interest from both sides of the food / pharmaceutical divide.

Areas of opportunity
Using specific examples from Brazil, China and India we will explore the significant opportunities for healthcare in this sector.

Unique challenges
We’ll discuss the associated challenges with nutritionals in emerging markets such as product definitions, approvals, health claims and manufacturing standards.

Research challenges and considerations
To help you truly maximise the opportunities, we will outline the market research challenges associated with nutritionals in emerging markets and discuss what can be done to overcome them.

Question and answer session
Following the presentation there will be a live Q&A. 


Watch the webcast: http://bit.ly/2oTpzFj

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Research conducted for Johnson and Johnson published in scientific journal

Findings from a study conducted by Dr. Chris Gaj, Vice President at Research Partnership, has been published in Clinical Genitourinary Cancer.

Connecting our Inizio Advisory capabilities to help a client address a threat to the brand, guide strategy and improve brand performance

The challenge Our client knew that prescribing of a key brand in a major market had slowed and needed to understand which patient segments were impacted so they could address...

Autoimmune conditions: Living With syndicated patient reports

The prevalence of autoimmune conditions is increasing, and despite significant advancements in treatments, individuals affected by these diseases may not be receiving the most effective management and care. In our...

How we elevated HCP market research engagement and insights using AI avatars for an immersive experience

Our client required an effective strategy for promoting discussions about self-paid vaccines with healthcare professionals (HCPs) during patient consultations. The conventional method of conducting market research would typically only deliver...

How we provided comprehensive real-world patient data for PAH using Therapy Watch, our syndicated market tracking solution

PAH is a specific type of pulmonary hypertension, which is a rare condition treated primarily in specialized centers. Our client needed to gain a comprehensive understanding of PAH patients, such...

Latest European developments and new talent at Research Partnership

Angela Duffy has been appointed as Managing Director for our European based ad hoc research teams. Angela has been an integral part of Research Partnership for 19 years, witnessing its...

New syndicated report – Living with Ulcerative Colitis 2024

Living with Ulcerative Colitis (UC) is a new syndicated patient report that presents valuable insights into the unmet needs and the burden experienced by patients living with UC. The report...

Webcast: AI in MRX: Harnessing the power of AI + people

Artificial intelligence (AI) in market research has surged in recent years, with a flow of innovative tools and techniques which have the potential to revolutionize the landscape. But to unlock...

Navigating challenges of MedTech research with rare-disease patients

Authored by: Tom Donnelly, MedTech Director and Amanda Pirraglia, Associate Director. Published in Quirk's Magazine.